Radiofrequency Ablation for Adenomyosis
Journal of Clinical Medicine · 23.04.2023 · 12 (9) · 3069
DOI: 10.3390/jcm12093069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.04.2023. Verfasst von Ioannis Dedes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by −63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
- Department of Gynecology and Obstetrics, University Hospital of Fribourg, 1752 Fribourg, Switzerland.
- Gynesonics®, Redwood City, CA 94063, USA.
ORCID-Profile: Ioannis Dedes, Georgios Kolovos, Arrigo Fruscalzo, David Toub, Anis Feki
Zitieren
APA
Dedes, I., Kolovos, G., Fruscalzo, A., Toub, D., Vaineau, C., Lanz, S., Imboden, S., Feki, A., & Mueller, M. D. (2023). Radiofrequency Ablation for Adenomyosis. Journal of Clinical Medicine, 12(9), 3069. https://doi.org/10.3390/jcm12093069
Vancouver
Dedes I, Kolovos G, Fruscalzo A, Toub D, Vaineau C, Lanz S, et al. Radiofrequency Ablation for Adenomyosis. Journal of Clinical Medicine. 2023;12(9):3069. doi:10.3390/jcm12093069
BibTeX
@article{Dedes2023,
author = {Dedes, Ioannis and Kolovos, Georgios and Fruscalzo, Arrigo and Toub, David and Vaineau, Cloé and Lanz, Susanne and Imboden, Sara and Feki, Anis and Mueller, Michael D},
title = {Radiofrequency Ablation for Adenomyosis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {9},
pages = {3069},
doi = {10.3390/jcm12093069}
}
EUVIMED